Çetin Demirdağ

8PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Rheumatology and arthritisRadiation therapyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 21, 2026
3D CT-based volumetric shrinkage predicts viable residual disease after chemotherapy in non-seminomatous germ cell tumors.

|Jul 20, 2026
Surgical strategy and outcomes in renal cell carcinoma with inferior vena cava tumor extension: A tertiary center experience.

|Jun 26, 2023
Rituximab in the management of retroperitoneal fibrosis: A single tertiary rheumatology care center experience.

Mert Oztas, Izzet Altun, Ali Yagiz Ayla

|Jun 14, 2022
Radiopharmaceutical for detecting PSMA - positive metastatic colon cancer: Matched-pair comparison of 18F-BF3-Cy3-ACUPA and 68Ga-PSMA PET/MRI.

Omer Aras, Cetin Demirdag, Harikrishna Kommidi

|Dec 28, 2020
Do urinary mast cell mediators predict immune response to BCG in patients with primary high-grade non-muscle invasive bladder cancer?

Muhammed Fatih Simsekoglu, Islim Kaleler, Bulent Onal

|Nov 01, 2020
Clinical outcomes of radical surgery in patients with renal carcinoma and associated venous thrombosis: Single-centre experience in a tertiary care institution.

Bulent Onal, Muhammed Fatih Simsekoglu, Mehmet Hamza Gultekin

Pageof 2

Frequent Collaborators

3 joint publications

Sertaç Asa

3 joint publications

Muhammed Fatih Simsekoglu

3 joint publications

Bulent Onal

3 joint publications

Kerim Sönmezoğlu